🇺🇸 FDA
Patent

US 12416008

Compositions and methods of use for small-molecule regulation of CRISPR-Cas9 activity using RNA aptamers

granted A61KA61K31/7105

Quick answer

US patent 12416008 (Compositions and methods of use for small-molecule regulation of CRISPR-Cas9 activity using RNA aptamers) held by The Regents of the University of Colorado, a Body Corporate expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/7105